FIRST TRACKS BIOTHERAPEUTICS, INC. (TRAX) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $35.00K; Additional Paid in Capital, Common StockUSD $193.34M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $0.00.
- 2026-03-31: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD (m); Additional Paid in Capital, Common StockUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-146.00K.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $0.00; Additional Paid in Capital, Common StockUSD $0.00; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-24.00K.
- 2025-06-30: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD (m); Additional Paid in Capital, Common StockUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD (m).
FIRST TRACKS BIOTHERAPEUTICS, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $35.00K | $193.34M | $0.00 | $-24.58M | $168.80M | 3 month · $8.32M |
| 2026-03-31 | (m) | (m) | (m) | $-146.00K | (m) | $257.46M | 3 month · $11.50M |
| 2025-12-31 | $0.00 | $0.00 | $0.00 | $-24.00K | $0.00 | $287.49M | (m) |
| 2025-06-30 | (m) | (m) | (m) | (m) | (m) | $270.66M | 3 month · $7.66M |
| 2025-03-31 | (m) | (m) | (m) | (m) | (m) | $357.72M | 3 month · $7.75M |
| 2024-12-31 | (m) | (m) | (m) | (m) | (m) | $391.60M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B |